-+ 0.00%
-+ 0.00%
-+ 0.00%
CRISPR Therapeutics Names Siva Sakhamuri Chief Technical Officer
Share
Listen to the news
CRISPR Therapeutics Names Siva Sakhamuri Chief Technical Officer
  • CRISPR Therapeutics appointed Sivakesava (Siva) Sakhamuri chief technical officer, effective immediately.
  • Sakhamuri joins from Orna Therapeutics, where he served as chief technical officer since 2024, bringing about 30 years of manufacturing leadership experience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020800PRIMZONEFULLFEED9867638) on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending